Our results show that the S1 subunit protein of SARS-CoV-2 is both sensitive and specific in distinguishing COVID-19 antibodies, suggesting its potential implication in large-scale serological testing, especially in determining the efficacy of SARS-CoV-2 vaccine. Here, PSMD1 is linked to COVID-19.